The vaccine can be administered to individuals who have received primary doses of Covaxin and Covishield Union health minister Mansukh Mandaviya on Friday approved Bharat Biotech International Ltd’s intranasal covid-19 vaccine, iNCOVACC, for emergency use in adults for both primary and booster shots.
The vaccine can be administered to individuals who have received primary doses of Covaxin and Covishield, the two most used vaccines against covid-19 in India. “We have given approval to the intranasal covid vaccine.
It can also be used as a ‘precaution’ dose. Now, the vaccine is being included in the covid-19 immunization programme and updated on CoWIN platform," Mandaviya said.
The CoWIN website maintains the records and books slots for covid vaccination. A nasal vaccine will allow India to quickly immunize its population during a surge in infections as they can be sprayed into the nose rather than injected into the arm, making the process painless.